Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07167381 · ClinicalTrials.gov registry record · NA
xDRIVE for Florida-based Cancer Patients
A NA study of Cancer and Lymphoma, sponsored by First Ascent Biomedical.
- Recruiting
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 2
- Study locations
NCT07167381: Recruiting NA study of Cancer and Lymphoma, sponsored by First Ascent Biomedical.
NCT07167381 is a NA study of Cancer and Lymphoma that is actively recruiting participants, run by First Ascent Biomedical. The registered enrollment target is 210 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07167381, a NA study of Cancer and Lymphoma, is actively recruiting participants, sponsored by First Ascent Biomedical.
- RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 2
- Study locations
Study Summary
Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision Medicine + Artificial Intelligence platform by assessing patient clinical benefit and health economics impacts. As this is a feasibility study, results will be returned to the physician and the physician may use the data to inform the next line of treatment. The investigator will run a prospective single-arm feasibility study providing the xDRIVE FPM AI platform to n = 210+ cancer patients throughout the state of Florida, especially those from underserved populations (pediatric patients and patients in Black, Brown, Hispanic, and rural communities).
Primary Outcome
Tumor tissues provided by patients will undergo drug sensitivity testing and molecular tumor profiling in order to identify individualized treatment options. Treatment recommendations from both tumor profiling methods will be returned to the patient and physician to support clinical decision-making. Return of data in a timeframe fast enough to support decision-making is critical for showing clinical feasibility of this approach around the state of Florida. Feasibility will be demonstrated if xDR
Conditions Studied
Interventions
- DIAGNOSTIC_TEST xDRIVE Tumor Profiling
Study Locations (2)
Florida
- First Ascent Biomedical - Miami
- Florida International University - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
What NCT07167381 shows while recruiting
NCT07167381 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower).
The record links to 8 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which xDRIVE Tumor Profiling is the first listed.
NCT07167381 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07167381 about?
NCT07167381 is a clinical study titled "xDRIVE for Florida-based Cancer Patients". Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision Medicine + Artificial Intelligence platform by assessing patient clinical benefit and health economics impacts. As this is a feasibility stud...
What is the current status of trial NCT07167381?
This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2025-11-01. Estimated completion is 2027-04-01.
What conditions does trial NCT07167381 study?
This clinical trial studies the following conditions: Cancer, Lymphoma, Solid Tumor Malignancies, Recurrence, Refractory.
What interventions are being tested in trial NCT07167381?
The interventions under investigation include: xDRIVE Tumor Profiling (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07167381?
This trial is sponsored by First Ascent Biomedical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07167381 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07167381's enrollment target sits among peer trials
210 225th of 615 higher than 391 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI